The bulls are returning to Solana as current price action shows readiness for 3x. But can current fundamental factors and market activity see Solana at a 3x surge this year? While assessing the growth factor of the Solana price, analysts say Remittix and Litecoin are showing bigger potential with a 10x to 20x likelihood.
The bull market is about to get more interesting this year with Remittix set for exchange listing and Litecoin whales back to make it the Bitcoin lite. Here is what to look at for Solana 3x and how an investment in Remittix and Litecoin could deliver about 40x this year.
Solana Set Off Bull Talk With Above 5 Months’ Resistance
The Solana price has reentered a bull phase by reclaiming a position above the $175 resistance. This zone represents a 5-month resistance that continues to see the price reverse in the last few months. However, this recent breakout is now primed to see the Solana price back on a new bull run that analysts say might be up to 3x. According to the analysis, Solana’s recovery above $175 signifies institutional traders’ renewed interest in the project.
The Solana ETF hype has remained a significant catalyst, fueling buying these last few weeks. This is, as reports suggest it could be getting approval before October. However, following the Solana price prediction from a technical front shows the coin ready to return to its major high of $206.
Moreover, as accumulation continues around the current support at $175, expert analysis shows a breakout beyond $206 could fuel strong demand momentum. Hence, while fundamental factors remain in favor of Solana, a surge beyond 3x will be dependent on early performance after the ETF approval.
Litecoin Gets Liquidity Boost With Institutional Support
The top Litecoin news today is about the Citadel $100 million investment, which is set to boost liquidity. However, before this update, the rise in a Litecoin ETF has picked up momentum, with the price recording 34% growth last month. The surge in Litecoin institutional interest is strengthening traders’ confidence and creating an overall positive sentiment.
Litecoin breakout has since become a topic of significance lately, as experts suggest a 10x to 20x surge could be brewing. In a follow-up to the Citadel story, MEI Pharma has also joined the Litecoin ecosystem, acquiring over 929,000 LTC for its crypto reserve. This rising confidence is also reflecting positively on the Litecoin ETF, which now stands at an 81% success rate.
Remittix Listing Pumps Up Its Breakout Rate
Remittix is set for exchange listing later this year after a successful presale surge that has seen it raise over $18.8 million in the last few months. However, while the feature of the Remittix project continues to fuel interest, the latest exchange announcement is adding new fuel to the fire.
According to the team announcement on X, the Remittix token will have its official listing this year, with the exchange set to be announced in a few days. This is fueling a new demand surge as experts predict more than 20x on the Remittix breakout.
The Remittix project has been tipped for success with several features backing its growth. Notable catalyst set to boost the Remittix adoption this year and beyond includes:
Next-gen solution that helps traders make cross-border payments to over 30 countries
Instant crypto to fiat conversion at the lowest rate
Beta wallet launch this quarter with enhanced capabilities
Official listing on a centralized exchange
Remittix promises to be the best new project this year and should not be missed, as the 40% bonus is set to end soon. There is still an opportunity to enjoy the 40% Bonus on Remittix by buying today.
Discover the future of PayFi with Remittix by checking out their project here:
Website: https://remittix.io/
Socials: https://linktr.ee/remittix
$250,000 Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway
This article contains information about a cryptocurrency presale. Crypto Economy is not associated with the project. As with any initiative within the crypto ecosystem, we encourage users to do their own research before participating, carefully considering both the potential and the risks involved. This content is for informational purposes only and does not constitute investment advice
